Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Molecular Biology and Genetics

Dominant-Negative Inhibition of Flk-1 Suppresses the Growth of Many Tumor Types in Vivo

Birgit Millauer, Michael P. Longhi, Karl H. Plate, Laura K. Shawver, Werner Risau, Axel Ullrich and Laurie M. Strawn
Birgit Millauer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael P. Longhi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl H. Plate
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura K. Shawver
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Werner Risau
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Axel Ullrich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurie M. Strawn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published April 1996
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Angiogenesis, the sprouting of new blood vessels from existing vessels, occurs in many physiological and pathological processes, including embryonic development, wound healing, and tumor growth. It is required for tumor growth because new blood vessel formation is necessary for tumors to expand beyond a minimum volume. Several growth factor receptor tyrosine kinases have been implicated in angiogenesis, including receptors for epidermal, fibroblast, and platelet-derived growth factors, as well as the receptors Flk-1/KDR, Flt-1, Tek/Tie-2, and Tie-1. Endothelial cells in the vessels of tumors express Flk-1/KDR, a receptor for vascular endothelial growth factor. Flk-1 was previously shown to play a role in angiogenesis and tumor formation of s.c. xenografts of C6 glioma cells using dominant-negative methodology. We now demonstrate that Flk-1 seems to be generally involved in the growth of a wide range of solid tumors, including mammary, ovarian, and lung carcinoma, as well as glioblastoma. Furthermore, survival times in rats bearing intracerebral tumors were prolonged using the same dominant-negative methodology. The involvement of Flk-1 in a variety of tumor types suggests an important role for Flk-1 in tumor angiogenesis.

Footnotes

  • ↵2 To whom requests for reprints should be addressed, at SUGEN, Inc., 515 Galveston Drive, Redwood City, CA 94063.

  • Received October 18, 1995.
  • Accepted February 1, 1996.
  • ©1996 American Association for Cancer Research.
PreviousNext
Back to top
April 1996
Volume 56, Issue 7
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Dominant-Negative Inhibition of Flk-1 Suppresses the Growth of Many Tumor Types in Vivo
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Dominant-Negative Inhibition of Flk-1 Suppresses the Growth of Many Tumor Types in Vivo
Birgit Millauer, Michael P. Longhi, Karl H. Plate, Laura K. Shawver, Werner Risau, Axel Ullrich and Laurie M. Strawn
Cancer Res April 1 1996 (56) (7) 1615-1620;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Dominant-Negative Inhibition of Flk-1 Suppresses the Growth of Many Tumor Types in Vivo
Birgit Millauer, Michael P. Longhi, Karl H. Plate, Laura K. Shawver, Werner Risau, Axel Ullrich and Laurie M. Strawn
Cancer Res April 1 1996 (56) (7) 1615-1620;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Molecular Biology and Genetics

  • Inactivation of BHD in Sporadic Renal Tumors
  • Widespread Bimodal Intrachromosomal Genomic Instability in Sporadic Breast Cancers Associated with 13q Allelic Imbalance
  • Opposite Effects of Modifiers of the ApcMin Mutation in Intestine and Mammary Gland
Show more Molecular Biology and Genetics

Articles

  • Mammary Gland Development, Reproductive History, and Breast Cancer Risk
  • The Prizes
  • Pax Genes and Their Role in Organogenesis
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement